Henrik Jespersen
7PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jun 28, 2023
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy.Vasu R Sah, Henrik Jespersen, Joakim Karlsson
|Aug 28, 2021
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma.Lars Ny, Henrik Jespersen, Joakim Karlsson
|Apr 22, 2020
Molecular profiling of driver events in metastatic uveal melanoma.Joakim Karlsson, Lisa M Nilsson, Suman Mitra
|Jun 02, 2019
Real-world data on PD-1 inhibitor therapy in metastatic melanoma.Anna Arheden, Joanna Skalenius, Sara Bjursten
|Jan 10, 2019
HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice.Elin M V Forsberg, Mattias F Lindberg, Henrik Jespersen
|Sep 29, 2017
Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model.Henrik Jespersen, Mattias F Lindberg, Marco Donia
Pageof 2
Frequent Collaborators
4 joint publications
Roger Olofsson Bagge
3 joint publications
Jonas A Nilsson
2 joint publications
Elin M V Forsberg
2 joint publications
Joakim Karlsson
2 joint publications
Hildur Helgadottir
2 joint publications
Lars Ny
2 joint publications
Anders Ståhlberg
1 joint publications
Ganesh Vilas Shelke
1 joint publications
Carl Jacob Holmberg
1 joint publications
Dimitrios Katsarelias
